# Relivion

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/relivion

- Industry: Medical Devices & Equipment
- Headquarters: Coral Springs, US
- Website: www.relivion.com/
- Latest round: Series A (Aug 1, 2017)
- Investors on record: 1

## About

Based in Florida, US, and founded in 2014, Neurolief Inc, trading under the name Relivion, operates as a manufacturer of medical equipment used as a digital therapeutics is used to treat neurological and neuropsychiatric conditions like depression and migraines. In December 2023, Neorolief Inc. raised venture funding from Sawai Group Holdings Co., Ltd.

Neurolief is a startup that uses digital medicines to help people with chronic neurological and neuropsychiatric illnesses. The company provide clinically approved neuromodulation systems that can be used at home or in the community. Relivion is a wearable neuromodulation therapy that targets migraine pain and symptoms. It activates the occipital and trigeminal nerves, which are related with migraines, and has a clinical efficacy without disruptive procedures. The device is customizable for patient comfort and includes a patient app for tracking therapy progress. The firm has locations in Coral Springs, Florida, as well as Netanya, Israel.

## Funding rounds

- Series A, Aug 1, 2017 — Champel Capital

## Investors

- Champel Capital (https://capitalatlas.ai/funds/champel-capital) — Series A